Brief: Sirnaomics Presents Positive Clinical Data Of STP705 For Focal Fat Reduction
Nov 1 (Reuters) - Sirnaomics Ltd:
* SIRNAOMICS PRESENTS POSITIVE CLINICAL DATA OF STP705 FOR
FOCAL
FAT REDUCTION
* SIRNAOMICS LTD: STP705 WAS WELL-TOLERATED AT ALL DOSES,
CONCENTRATIONS, AND VOLUMES
Further company coverage: 2257.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sirnaomics
See all newsBrief: Sirnaomics To Issue 2.4 Million New Shares At Hk$4.69 Each Under General Mandate
Brief: Sirnaomics Says Chairman Purchases 38,000 Shares At Average Price Hk$5.93 Per Share
Brief: Sirnaomics Ltd To Issue 17.4 Million Subscription Shares
Brief: Sirnaomics Says Poon Hung Fai Appointed As Chairman
Brief: Sirnaomics Posts FY Net Income USD -50.2 Million